---
title: "Wolverine World Wide, Inc. Stock 12‑Month Price Target Raised to $22, Implies 22% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295849465.md"
description: "Wolverine World Wide, Inc.'s 12-month average price target has been raised to $22 by 10 analysts, up from $21.7, implying a 22% upside based on the Aug. 12 closing price. The consensus rating remains 'Buy' among 11 covering analysts, with 6 Buys and 5 Holds."
datetime: "2026-08-13T21:20:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295849465.md)
  - [en](https://longbridge.com/en/news/295849465.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295849465.md)
generator: "portal-rs"
---

# Wolverine World Wide, Inc. Stock 12‑Month Price Target Raised to $22, Implies 22% Upside

-   According to estimates from 10 analysts, Wolverine World Wide, Inc. stock's average price target has risen from $21.7 to $22, with forecasts ranging from $16 to $29 per share
-   Based on the Aug. 12 closing price, the updated target implies approximately 22% potential upside
-   Consensus rating remains at “Buy” across 11 covering analysts, with 6 Buys, 5 Holds and 0 Sells

Explore more price target data and ratings for Wolverine World Wide, Inc. on the , and track all previous and future analyst recommendations for Wolverine World Wide, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [WWW.US](https://longbridge.com/en/quote/WWW.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Wolverine World Wide Q2 profit beats estimates, tariffs weigh on margins](https://longbridge.com/en/news/295783383.md)
- [These Analysts Raise Their Forecasts On Wolverine World Wide Following Strong Q2 Results](https://longbridge.com/en/news/295936328.md)
- [Should Earnings Beat Require Action From Casey's General Stores Stock Investors?](https://longbridge.com/en/news/298400751.md)
- [Should Limited Edition Fashion Launch Require Action From Dillard's (DDS) Investors?](https://longbridge.com/en/news/298378972.md)
- [Nektar Therapeutics (NKTR) Lands Lancet Backing, Is The Upside Already Priced In?](https://longbridge.com/en/news/298137481.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**